seed
Stage
3
Investors
About
BiomeSense develops AI-enabled technology and bioinformatics platforms for continuous, low-cost, and longitudinal analysis of the human gut microbiome to support personalized medicine and microbiome-based biomarker discovery.
Explore BiomeSense's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.